Objective: Women with a history of preeclampsia are at an increased risk of hypertension and structural brain changes. However, the combined effect of both preeclampsia and late-life hypertension on brain structural changes is not known and was investigated in this study.
INTRODUCTION
P reeclampsia is a hypertensive pregnancy disorder that affects around 3-8% of all pregnancies worldwide [1] . Women who experienced preeclampsia that resolved after delivery have a four-fold increased risk of developing hypertension, on average 8-10 years earlier, compared with women who had normotensive pregnancies [2] . In addition, women with histories of hypertensive pregnancy disorders have smaller brain volumes measured with MRI) decades after the pregnancy compared with women with histories of normotensive pregnancies [3] . However, studies have not determined the combined effect of both a history of preeclampsia and late-life hypertension on the risk of abnormal findings on brain MRI later in life.
MRI provides a sensitive measure of the presence of cerebrovascular disease lesions defined by white matter hyperintensities (WMH), cortical and subcortical infarctions, and microbleeds. WMH are areas of increased signal in subcortical and periventricular white matter on T 2 -weighted images that are associated with cerebral small vessel disease in older adults [4] . Infarctions and microbleeds are cerebrovascular disease-related lesions that are visible on MRI. Gray matter atrophy, a marker of neuronal loss, is also associated with increased severity of cerebrovascular disease and, therefore, can reflect a global burden of cerebrovascular disease on the brain [4] .
The purpose of this study was to determine the impact of a history of preeclampsia and late-life hypertension on MRI findings associated with cerebrovascular disease and structural MRI measures of gray matter atrophy.
METHODS

Study design and participants
The current study was approved by the Mayo Clinic and Olmsted Medical Center Institutional Review Boards and all participants provided written informed consent. The Rochester Epidemiology Project (REP) medical recordslinkage system was used to identify women (n ¼ 40) with a history of preeclampsia and age-matched and paritymatched women (n ¼ 40) with a history of normotensive pregnancy, as described previously [5] . Briefly, to be eligible, the women had to be residents of Olmsted County, Minnesota, USA when delivering a baby from a pregnancy lasting more than 20 weeks between 1976 through 1982 (n ¼ 990). Medical records of women identified by Hospital International Classification of Diseases Adapted codes were reviewed for indication of a possible hypertensive pregnancy disorder. A possible hypertensive pregnancy disorder was then confirmed as preeclampsia if a woman had at least one preeclamptic pregnancy from 1976 through 1982 and met the following criteria: at least two blood pressure (BP) readings of a SBP more than 140 or a DBP more than 90 mmHg that occur at least 4 h apart after more than 20 weeks' gestation; and proteinuria. Preeclampsia could have been experienced at any pregnancy and there were no twin pregnancies. After confirmation of history of preeclampsia, 77 eligible women from the REP were invited to participate in the study. Of those, 25 (32%) refused, seven (9%) did not respond, and five (6%) were found to be ineligible due to temporal lobe epilepsy (n ¼ 1), lung cancer (n ¼ 1), contraindication for MRI (n ¼ 1), possible transient ischemic attack (n ¼ 1), medication that interferes with blood tests (n ¼ 1). after screening for additional medical conditions not identified in the medical record. Finally, we identified 40 women with histories of preeclampsia that met the inclusion and exclusion criteria of this study. In addition, women were identified as having 'severe disease' if they had SBP more than 160 or DBP more than 110 during pregnancy, recurrence in another pregnancy, intrauterine fetal demise, or delivery less than 34 weeks gestation due to preeclampsia [5] .
Women with histories of normotensive pregnancies, who were identified as those with none of the possible hypertensive pregnancy codes were age-matched and parity-matched to the 40 woman with a history of preeclampsia. Of the 104 women with histories of normotensive pregnancies who were contacted, 18 (17%) refused, 41 (39%) did not respond, and 5 (5%) were interested in participating, but they were not included in the study because other matched controls (n ¼ 40) were already in the study.
The medical records were then fully abstracted for demographic and clinical information at the time of each pregnancy: date of birth, ethnicity, education, marital status, family history, prenatal BPs, weight, laboratory values (such as creatinine, proteinuria, liver enzymes), medications, tobacco use, alcohol use, pregnancy complications, seizures, persistent headache, epigastric pain, coma, chronic hypertension, diabetes, stroke, cardiac disease, renal disease, hepatic disease, autoimmune disorder, admission into the ICU, postpartum depression, and hyperreflexia [5] .
Women with a clinical diagnosis of cardiac disease (e.g. congestive heart failure), stroke, any cancer (with the exception of nonmelanoma skin cancer), autoimmune disease (e.g. multiple sclerosis, lupus) were excluded because these entities can cause structural changes on MRI and confound investigations of preeclampsia-related vascular damage.
The medical records of the women were abstracted to identify whether they had chronic hypertension at the time of enrollment in the current study. Presence of hypertension was defined by either the current use of antihypertensive drugs as abstracted from the medical record or by an average of three measurements with a mean SBP more than 140 mmHg and/or mean DBP more than 90 mmHg. Initiation of antihypertensive treatment was considered as the time of onset of hypertension. Four groups of women were investigated in this study: first, women with a history of normotensive pregnancy who have current hypertension, second, women with a history of normotensive pregnancy who do not have current hypertension, third, women with a history of preeclampsia who have current hypertension, and fourth, women with a history of preeclampsia who do not have current hypertension.
MRI methods
Image acquisition
All women agreed to have MRI acquired for this study. 
Quantification of white matter hyperintensities
The total volume of WMH, a marker of cerebral small vessel disease, was quantified using a semiautomated algorithm [6] . T 1 -weighted images were segmented using statistical parametric mapping (version 5) (SPM5) [7] and aligned to FLAIR images, and corresponding brain masks were used to remove nonbrain tissue and voxels that had a high probability of being cortical gray matter. Voxels that were deemed candidate WMH locations were clustered via connected-components. Clusters were removed if they consisted of a single isolated voxel, were mostly located outside regions classified as white matter, or contained no suprathreshold FLAIR voxels after blurring. Remaining clusters were then manually edited by a trained image analyst (S.M.Z.) who was blinded to the diagnostic group assignment to correct for WMH misclassifications. Following assessment of infarcts (described in the next section), the hyperintense voxels associated with infarcts were marked and excluded from the total WMH volume measurement as they are attributed to distinct pathophysiologic processes. The total WMH volume was adjusted for total intracranial volume. This accounts for differences in the relative head size/stature of the participants.
Assessment of infarcts and microbleeds
Cerebral infarcts were identified on FLAIR MRI and microbleeds on T 2 Ã GRE images by a trained image analyst (S.M.Z.) and confirmed by a radiologist (K.K.) who were both blinded to the diagnostic group category. We have previously shown excellent intrarater reliability in assessment of cortical and subcortical infarctions using this method [8, 9] . Cortical infarcts were defined as areas of increased signal intensity on FLAIR MRI in the cortical gray matter. Subcortical infarcts were defined as lesions of at least 3-mm surrounded by a hyperintense rim in the subcortical gray matter or white matter. Subcortical infarcts were differentiated from dilated perivascular spaces based on the shape of the hypointense center and the surrounding hyperintesity. Microbleeds were defined as hypointense lesions 10 mm or less in diameter on T 2 Ã GRE.
Gray matter volumes
Total gray matter volume was calculated using FreeSurfer version 5.3 (www.freesurfer.net; access year 2013) and adjusted for total intracranial volume using a linear regression.
Voxel-based morphometry
Voxel-based analysis was performed to determine regional structural differences in cortical gray matter using our previously described voxel-based morphometry technique using SPM5 (http://www.fil.ion.ucl.ac.uk/spm; access year 2005) [7, 10, 11] .
Statistical analysis
Characteristics of participants and differences among the four groups were assessed using Fisher's Exact Tests for categorical variables and Kruskal-Wallis One-way Analysis of Variance by Ranks Tests for continuous variables (Table 1) . Differences in MRI measures across the four groups were first assessed using two-way factorial analysis of covariance, with preeclampsia and current hypertension as our categorical predictors of interest, and adjustment for age and total intracranial volume on logarithmic scale due to skewness [log(TIV)]. Results from voxel-based morphometry were assessed at a statistical threshold of P less than 0.001 with a cluster size correction of at least 500 voxels.
RESULTS
The characteristics of the four groups of women in this study are listed in Table 1 . At the time of MRI, women were similar in age, years past menopause, years of education, menopausal hormone therapy use, migraine, and diagnoses of dementia, hyperlipidemia, and diabetes. Of the 40 women with a history of preeclampsia, 24 had current hypertension (60%). Of the 40 women with a history of normotensive pregnancy, eight (20%) had current hypertension. There were seven women with a history of preeclampsia who had a 'severe disease' as defined earlier.
Three of these women had current hypertension and four did not have current hypertension. Within each pregnancy group, mean SBP was greater in women with current hypertension than without current hypertension (P < 0.02; Table 1 ). However, mean SBP did not differ between women with current hypertension, regardless of a history of normotensive pregnancy or preeclampsia (P > 0.1) nor did it differ between women with no current hypertension regardless of pregnancy Table shows demographics and cardiovascular risk factor information of the participants, comparing the four groups of women. P values were generated using Fisher's Exact and Kruskal-Wallis one-way analysis of variance by Ranks Tests. Significant P value shows that within each pregnancy group, mean SBP was greater in women with current hypertension than without hypertension (P < 0.02). Nonsignificant P values indicate that none of the four groups differed on those characteristics. IQR, interquartile range; WMH, white matter hyperintensity. a Differences were among those with and without current hypertension within each pregnancy group. Results from Fisher's Exact test between two groups with history of Preeclampsia only.
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Journal of Hypertension www.jhypertension.comgroup (P > 0.99). Of the eight women with a history of normotensive pregnancy who had current hypertension, four were diagnosed with hypertension at the time of their participation in the study. In all four of these women the SBP was more than 160 mmHg. On the contrary, of the 24 women with a history of hypertensive pregnancy who had current hypertension, only two were diagnosed with hypertension at the time of their participation in the study. Thus, the proportion of women who were already on antihypertensive drugs was higher for the women with a history of hypertensive pregnancy who had current hypertension (22/24; 92%), compared with women with a history of normotensive pregnancy who had current hypertension (4/8; 50%) (P ¼ 0.02). The most commonly used type of antihypertensive drugs for the treatment of current hypertension was diuretics. Of the eight women with a history of normotensive pregnancy and current hypertension, two (25%) were being treated with a diuretic. Of the 24 women with a history of hypertensive pregnancy with current hypertension, 11 (46%) were being treated with a diuretic. The use of diuretics was not different between women with a history of normotensive or hypertensive pregnancy (P ¼ 0.42). Although all women had some WMH present on FLAIR MRI, the volume of WMH, adjusted for total intracranial volume and age, did not differ among the groups (P ¼ 0.51). Furthermore, cerebrovascular disease-associated lesions, such as infarcts (P ¼ 0.66) and microbleeds (P > 0.11), did not differ among groups (Table 2) .
Total gray matter volumes were smaller in women with a history of preeclampsia and current hypertension compared with all other groups (Fig. 1) . After adjusting for age and log(TIV) the interaction between the history of preeclampsia and current hypertension were associated with smaller gray matter volumes (P ¼ 0.04). Voxel-based morphometry identified smaller gray matter volumes in the occipital cortex, spanning much of Brodmann areas 17 and 18, and medial aspects of 19 in both hemispheres in women with a history of preeclampsia and current hypertension (Fig. 2a) compared with women with a history of preeclampsia and no current hypertension. These Brodmann areas include the primary visual and visual association cortices. Furthermore, women with a history of preeclampsia and current hypertension had smaller gray matter volumes in the prefrontal and sensorimotor cortices in both hemispheres compared with women with a history of normotensive pregnancy and no current hypertension (Fig. 2b ).
DISCUSSION
The current study investigated the impact of pregnancy history and late-life hypertension on structural changes in the brain decades after the pregnancy. Women who had a history of preeclampsia and later developed chronic hypertension had smaller gray matter volumes than women with a history of preeclampsia but did not later develop hypertension and women with a history of normotensive pregnancy with or without later-life hypertension after adjusting for age. This result is in agreement with previous studies reporting both smaller brain volumes in women with histories of hypertensive pregnancy disorders compared with women with histories of normotensive pregnancies [3] as well as data from the Women's Health Initiative Memory Study reporting an association between late-life hypertension and smaller brain volumes in older women [12] . Therefore, the current study brings clarity to the risk of future brain changes following a hypertensive pregnancy by indicating contribution of late life hypertension in these women as they age. However, in both the current study and the previous study in women [3] with a history of hypertensive pregnancy, women did not differ in their MRI markers of cerebrovascular disease. This result could be due to the women's relatively young age (i.e. mid-life) since the strongest risk factor for cerebrovascular disease is older age [9, [13] [14] [15] [16] [17] [18] , the current use of antihypertensive medication, or to exclusion of women with cardiovascular disease in this study. Alternatively, the relatively small sample sizes of the four groups might have limited our power to detect group differences in the presence of cerebrovascular disease lesions on MRI.
Voxel-based analysis showed that women with a history of preeclampsia and current hypertension had smaller gray matter volumes in the occipital lobe involving the primary visual and visual association cortices than women with a history of preeclampsia and no current hypertension (Fig. 2a) . The localization of these changes is similar to those identified from neuroimaging studies of women who experienced eclampsia and a clinical syndrome known as posterior reversible encephalopathy syndrome (PRES). PRES is characterized by neurologic symptoms, such as headache, altered consciousness, visual abnormalities, and seizures, together with vasogenic edema in posterior brain regions on neuroimaging [19] . However, none of the preeclemptic patients in our study had a diagnosis of PRES. In the current study, the increased atrophy was seen in the occipital lobe only in women with a history of preeclampia who went on to develop hypertension and was not seen in areas typically affected in patients with cardiovascular disease (prefrontal, sensorimotor cortices). This observation could indicate that all of the women who experienced preeclampsia have a similar burden of cardiovascular disease-related neuronal loss, but those who went on to develop hypertension later in life show increased neuronal loss in the posterior circulation. A previous study suggests that age combined with hypertension most severely affects the occipital and temporal lobes [20] . As women with a history of preeclampsia are at a four-fold increased risk for developing hypertension later in life [2] , it might be expected that women with a history of preeclampsia who go on to develop hypertension would develop atrophy in the occipital gray matter as they age. Alternatively, the atrophy of the occipital gray matter might have occurred at an earlier age in the women with a history of preeclampsia and current hypertension. That is, the combined effect of preeclamptic pregnancy and hypertension may shift the aging processes. The small numbers of women with a history of normotensive pregnancy and hypertension later in life (n ¼ 8) limited our ability to investigate the segregated impact of pregnancy history alone on the late-life hypertension and gray matter loss. However, the higher percentage of women with hypertension later in life in the women with a history of preeclampsia (60%; n ¼ 24) compared with the women with a history of normotensive pregnancy (20%; n ¼ 8) is consistent with the literature. Another limitation of this study is that it was not possible to ascertain the actual age of onset of hypertension. Instead, initiation of antihypertensive treatment was considered as the time of onset of hypertension in these women, which did not differ between the normotensive and hypertensive pregnancy groups with current hypertension. It is possible that hypertension was present before it was diagnosed and treated. Thus, it was not possible to determine whether the length of hypertension had an impact on the gray matter volumes. A longitudinal study beginning from the time of the pregnancy to the onset of hypertension is needed to clarify the temporal relationships among disease processes. Also, it is possible that chronic use of diuretics could impact brain volumes; however, the effects are expected to be global. In addition, evidence from prior literature indicates that diuretic use for treating hypertension does not appear to impact brain structure [21] .
Atrophy of gray matter regions in the prefrontal and sensorimotor cortices characterize patients with vascular disease including hypertension [22] [23] [24] [25] [26] . Atrophy in these brain areas were found only between women with a history of preeclampsia and current hypertension compared with women with a history of normotensive pregnancy and no current hypertension (Fig. 2b) . We did not find any differences in these gray matter volumes between women based on their pregnancy history who did not have hypertension. That is, we saw no effect of history of preeclampsia alone, without the added effect of current hypertension in these brain regions. However, the small sample of women with a history of normotensive pregnancy and hypertension later in life may be the reason we were not able to find any regional patterns of atrophy in voxel-based analysis when women with a history of preeclampsia and current hypertension were compared with this group.
In conclusion, our findings suggest that women who have pregnancy-associated hypertension are particularly susceptible to posterior brain injury. Injury in posterior brain regions is commonly associated with cardiovascular disease and is seen in women affected by PRES, thereby similar mechanisms may be contributing to these posterior brain changes in preeclamptic women who developed hypertension later in life. Although our study cannot address the temporal sequence of chronic hypertension and brain atrophy after the preeclamptic pregnancy, the observed brain structural abnormalities among these women may indicate a more severe disease process during the preeclamptic pregnancy, which may have led to development of both hypertension and cortical atrophy later in life. In this case, late-life hypertension reflects more severe preeclampsia that led to volume loss in the gray matter. Alternatively, preeclampsia and hypertension synergistically may have contributed to the gray matter volume loss.
